(HealthDay)—Early in the COVID-19 pandemic, anecdotal reports suggested that infusing very sick patients with the blood plasma of people who'd survived the disease might help boost outcomes.
Nov 25, 2020
0
2
To find out whether experimental COVID-19 vaccines are safe and effective, researchers design clinical trials involving thousands of volunteers, divided into groups that receive either the drug under investigation or a placebo.
Nov 19, 2020
0
3
American biotech firm Moderna has released early results from its phase 3 clinical trials, announcing in a press release on Monday (US time) that its COVID vaccine has an efficacy of 94.5%, according to an "interim analysis" ...
Nov 17, 2020
0
1
The United States' top infectious disease scientist on Monday hailed early trial results from Moderna's Covid-19 vaccine as "stunningly impressive," and said the findings were an emphatic validation of experimental mRNA technology ...
Nov 17, 2020
0
3
US biotech firm Moderna on Monday announced its experimental vaccine against COVID-19 was almost 95 percent effective, marking a second major breakthrough in the quest to end the pandemic.
Nov 16, 2020
0
17
Hospitalised COVID-19 patients in the UK who received an inhaled form of interferon beta-1a (SNG001) were more likely to recover and less likely to develop severe symptoms than patients who received a placebo, according to ...
Nov 13, 2020
0
1
(HealthDay)—Vosoritide increases bone growth velocity in children with achondroplasia, the most common form of dwarfism, according to a study recently published in The Lancet.
Oct 27, 2020
0
2
If a coronavirus vaccine is authorized in the United States before the end of the year, will trial participants who received a placebo rush out to get vaccinated?
Oct 23, 2020
0
4
With vaccines against COVID-19 inching closer, U.S. regulators took an unusual step Thursday in asking outside scientists: Are the government's standards high enough to adequately judge the shots?
Oct 22, 2020
0
1
The US Food and Drug Administration made public its guidance for issuing emergency approval for a COVID-19 vaccine on Tuesday, making it clear it wants to see follow-up two months after trial volunteers have their second ...
Oct 07, 2020
0
5
